Related Experiment Video
Updated: Nov 5, 2025

08:51
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
1.7K
DSCMF: prediction of LncRNA-disease associations based on dual sparse collaborative matrix factorization
Jin-Xing Liu1, Ming-Ming Gao1, Zhen Cui1
1School of Computer Science, Qufu Normal University, Rizhao, China.
BMC Bioinformatics
|May 13, 2021
Summary
This study introduces a novel Dual Sparse Collaborative Matrix Factorization (DSCMF) method to predict long non-coding RNA-disease associations (LDAs). The DSCMF method significantly improves prediction accuracy, aiding in disease research and treatment strategies.
Area of Science:
- Genomics
- Bioinformatics
- Computational Biology
Background:
- Long non-coding RNAs (lncRNAs) are increasingly linked to human diseases.
- Identifying lncRNA-disease associations (LDAs) is crucial for disease prevention and treatment.
- Current methods for predicting LDAs are time-consuming and labor-intensive.
Purpose of the Study:
- To develop an efficient computational method for predicting lncRNA-disease associations (LDAs).
- To enhance the accuracy and reliability of LDA prediction.
- To provide a valuable tool for researchers in the field of lncRNA and disease studies.
Main Methods:
- Proposed a Dual Sparse Collaborative Matrix Factorization (DSCMF) method.
- Incorporated L2,1-norm to enhance sparsity.
- Utilized Gaussian interaction profile kernel to improve network similarity between lncRNAs and diseases.
Main Results:
- Achieved an Area Under the Curve (AUC) value of 0.8523.
- Demonstrated the effectiveness of DSCMF through ten-fold cross-validation.
- Detailed analysis of experimental results for prostate cancer, breast cancer, ovarian cancer, and colorectal cancer.
Conclusions:
- The DSCMF method shows significant promise for advancing lncRNA-disease association research.
- The developed method offers a more efficient approach to predicting LDAs.
- The study provides a valuable resource for understanding the roles of lncRNAs in human diseases.
Related Concept Videos
lncRNA - Long Non-coding RNAs
9.2K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.2K
lncRNA - Long Non-coding RNAs
3.1K
3.1K
Genome-wide Association Studies-GWAS
14.8K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.8K

